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To assess the knowledge and attitudes of pregnant Japanese women regarding non-invasive prenatal 
testing (NIPT).  Between March and June 2013,  557 pregnant women in the Hyogo and Hiroshima 
Prefectures were surveyed using an anonymous,  self-completed questionnaire.  A total of 91.9ｵ 
respondents (512/557) stated that they “agree” or “conditionally agree” with NIPT implementation in 
Japan.  Approximately 28.5ｵ of respondents stated that they knew that the accuracy of a positive 
NIPT result can be aﬀected by motherʼs age and background,  while 34.5ｵ of respondents stated that 
it was necessary for pregnant women with a positive result to undergo fetal chromosome diagnosis 
using amniocentesis; both percentages were low.  Additionally,  92.3ｵ of respondents would “like a 
detailed explanation of the test,” 65.1ｵ of them would “like psychological support if the NIPT test 
results came back positive,” and 5.7ｵ would terminate the pregnancy if the NIPT test results came 
back positive without undergoing fetal chromosome diagnosis via amniocentesis.  Although a high 
proportion of pregnant Japanese women agreed with the introduction of NIPT into Japanese obstetri-
cal care,  there was insuﬃcient knowledge regarding the test.  It is necessary for women undergoing 
NIPT to be provided suﬃcient information and psychological support.
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he technology of screening for diagnosing con-
genital diseases and abnormalities in fetuses has 
rapidly developed in the past few decades.  In many 
western countries,  prenatal screening for Down syn-
drome is oﬀered to pregnant women [1].
　 The possibility of diagnosing aneuploidies with a 
maternal blood test emerged with the discovery of cell-
free fetal DNA in 1997 [2].  Non-invasive prenatal 
testing (NIPT) for Down syndrome was ﬁrst imple-
mented clinically in the USA and China/Hong Kong 
[3].  NIPT involves comprehensive sequencing of cell-
free fetal DNA from maternal plasma [4-8],  and 
enables the detection of fetal chromosomal abnormali-
ties (e.g.,  trisomy 21,  18,  13) as early as the 10th 
week of pregnancy.
　 Using NIPT to screen fetuses for trisomy 21 pro-
vides 98.6ｵ sensitivity,  with a maximum false-posi-
tive rate of 0.8ｵ [5,  9-11].  Similar numerical values 
were reported in Japanese newspapers in 2012.  
These results,  however,  were achieved in a study 
targeting high-risk groups [4,  6].  However,  it is 
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believed that only a small proportion of pregnant 
women are aware of the details of NIPT,  e.g.,  the fact 
that the sensitivity and the rate of false-positives can 
vary depending on the background of the pregnant 
women [4,  5].
　 Furthermore,  similar to screening of maternal 
serum and nuchal translucency (NT) thickness,  NIPT 
does not provide a deﬁnitive diagnosis; if the test 
result is positive,  fetal chromosomal diagnosis using 
amniocentesis must be undertaken to determine the 
diagnosis.  One concern is that pregnant women who 
are not aware of this two-step procedure of diagnosis 
may choose to abort the fetus without further genetic 
amniocentesis if they receive a positive result [4].
　 In Japan,  for prenatal testing of fetal chromosomal 
abnormalities,  maternal serum screening (α-fetoprotein;  
AFP,  human chorionic gonadotropin; hCG,  unconju-
gated estriol; uE3,  Inhibin A),  and NT measurement 
have been conventionally performed.  Fetal chromo-
somal abnormalities have been diagnosed by amniocen-
tesis,  whereas chorionic villus sampling (CVS) is 
hardly ever performed in Japan.
　 In April 2013,  NIPT started being implemented in 
Japan [12].  Professional organizations such as the 
Japan Society of Obstetrics and Gynecology recom-
mended NIPT for women who meet the following 
conditions: (i) the fetal ultrasound suggests the pos-
sibility of a fetal chromosomal abnormality; (ii) 
maternal serum screening suggests the possibility of a 
fetal chromosomal abnormality; (iii) a previous preg-
nancy had a fetal chromosomal abnormality; (iv) 
pregnancy occurs at an older age (ｧ35),  or (v) triso-
mies 21 and 13 in the fetus are considered possible 
due to a balanced Robertsonian translocation in either 
parent [Guidelines for NIPT in Japan: Japan Society 
of Obstetrics and Gynecology.  URL http://www.jsog.
or.jp/news/pdf/guidelineForNIPT_20130309.
pdf#search＝ʻNIPT＋ｵE6ｵ8Cｵ87ｵE9ｵ87ｵ9Dʼ 
(in Japanese) [accessed on 14 April 2014]].
　 Previous studies on the attitudes of pregnant 
women to maternal serum screening,  NT measurement 
and fetal chromosome diagnosis by amniocentesis have 
clariﬁed that they have insuﬃcient knowledge and 
information about prenatal diagnoses to make informed 
decisions [13-16],  and that providing this knowledge 
reduces the anxiety of pregnant women [17].  However,  
there are no studies in pregnant Japanese women on 
their knowledge of NIPT,  or their attitudes toward 
undergoing NIPT.  
　 In the present study,  we investigated knowledge 
and attitudes toward NIPT among pregnant Japanese 
women in Japan.
Methods
　 Between March and June 2013,  760 pregnant 
women undergoing pregnancy health checks at one of 
5 general maternity clinics or hospitals in Hyogo and 
Hiroshima Prefectures in Japan were asked to com-
plete an anonymous questionnaire after informed con-
sent.  Participants ﬁlled out their age,  educational 
background,  previous pregnancies,  and history of 
infertility treatment,  as well as responding to other 
questions about their background.  The survey 
addressed their knowledge of NIPT,  along with their 
attitudes  as whyone would undertake the test.  Women 
with known health problems or known fetal complica-
tions were excluded from the subjects.  Questionnaire 
responses were obtained from 591 pregnant women.  
Data from 557 respondents were eventually analyzed.
　 Data were analyzed using SPSS for Windows 
[ver.20] (IBM Inc.,  Chicago,  IL,  USA),  using 
descriptive statistics,  the chi-squared test and the t 
test.  Statistical signiﬁcance was set at p＜0.05.  
Results are presented as mean ± standard deviation.
　 This study was conducted with the approval of the 
Research Ethics Committee of Graduate School of 
Health Sciences,  Okayama University of Japan.
Results
　 Background of respondents. Questionnaire 
responses were obtained from 591 pregnant women 
(response rate 77.8ｵ); responses of 34 were consid-
ered invalid,  such that data from 557 respondents 
were eventually analyzed (valid response rate 73.3ｵ).  
The mean gestational period of the respondents was 
26.1±8.4 [5-40] weeks,  and the mean age was 32.1
±4.6 [18-44] years (Table 1).  In all,  49.2ｵ 
respondents were primigravida,  16.9ｵ had undergone 
infertility treatment,  23.0ｵ had experienced a mis-
carriage,  and 13.1ｵ had experienced medical termi-
nation of a pregnancy.  The percentages of women 
agedｧ35 years who were primigravida,  had received 
infertility treatment,  or had experienced a miscar-
riage were signiﬁcantly higher than those of women 
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agedｦ34 years.  These rates were almost the same as 
those of the general Japanese population.
　 Knowledge of NIPT. In total,  76.5ｵ respon-
dents answered that they either “knew well” or “had 
heard of” NIPT (Table 2).  Women agedｧ35 years 
had a higher level of knowledge regarding all types of 
prenatal testing than those agedｦ34 years.  Nevertheless,  
a high overall level of knowledge was observed 
regarding the fact that “the test can screen whether or 
not the fetus has Down syndrome” (74.5ｵ).  However,  
not many women seemed to be aware of the facts that 
“At present,  the anticipated conditions include only 
three chromosomal abnormalities (trisomy 21,  18,  
and 13)” (16.7ｵ).  Furthermore,  there were low rates 
of women who knew that “if a positive test result is 
returned,  it is necessary to undergo fetal chromosome 
diagnosis using amniocentesis,  to diagnose whether or 
not there is actually an abnormality with the fetus” 
(34.5ｵ),  and “the accuracy of a positive test result 
can be aﬀected by the age and background of the 
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Table 1　 Background of respondents
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Gestational age in weeks 26.1±8.4[5-40] 26.0±8.3[8-40] 26.4±8.8[5-40] 0.674
Age (years) 32.1±4.6[18-44] 29.8±3.3[18-34] 37.3±2.1[35-44]
Parity
　Primiparous 274 (49.2%) 200 (52.2%) 74 (42.5%) ＜0.05
　Multiparous 283 (50.8%) 183 (47.8%) 100 (57.5%)
Experience with infertility treatment 94 (16.9%) 38 (9.9%) 56 (32.2%) ＜0.001
Experience with miscarriage 128 (23.0%) 69 (18.0%) 59 (33.9%) ＜0.001
Experience with artiﬁcial termination 73 (13.1%) 54 (14.1%) 19 (10.9%) 0.303
Experience with stillbirth 10 (1.8%) 8 (2.1%) 2 (1.1%) 0.349
Table 2　 Knowledge of NIPT in pregnant women
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Have you heard of NIPT?
　　Know it well 35 (6.3%) 21 (5.5%) 14 (8.0%)
　　Have heard of it 391 (70.2%) 257 (67.1%) 134 (77.0%) 0.676
　　Do not know it 131 (23.5%) 105 (27.4%) 26 (14.9%)
Test is carried out by taking blood from the mother 417 (74.9%) 271 (70.8%) 146 (83.9%) ＜0.01
Used to screen for Down syndrome in fetus 415 (74.5%) 279 (72.8%) 136 (78.2%) 0.182
If a positive test result is returned from the NIPT,  it is necessary 
to undergo fetal chromosome diagnosis using amniocentesis,  to 
diagnose whether or not there is actually an abnormality in the 
fetus
192 (34.5%) 118 (30.8%) 74 (42.5%) ＜0.01
The accuracy of a positive test result can be aﬀected by the age 
and background of the mother
159 (28.5%) 105 (27.4%) 54 (31.0%) 0.381
The test can be carried out from the 10th week of pregnancy 113 (20.3%) 63 (16.4%) 50 (28.7%) ＜0.01
If the test result is negative,  the probability that the fetus has no 
chromosomal abnormality is almost 100%,  regardless of age or 
background
112 (20.1%) 62 (16.2%) 50 (28.7%) ＜0.01
At present,  the anticipated condition include only three
　chromosomal abnormalities (trisomy 21,  18,  and 13)
93 (16.7%) 45 (11.7%) 48 (27.6%) ＜0.001
Test result accuracy is 95% in pregnancies among older women,  
and those indicated in ultrasound testing as having
　the possibility of a fetal abnormality those had children
70 (12.6%) 47 (12.3%) 23 (13.2%) 0.755
Test result accuracy is 75% if all pregnancies in women over the 
age of 35 are tested,  and 30% if all pregnancies are tested
36 (6.4%) 28 (7.3%) 8 (4.6%) 0.227
mother” (28.5ｵ).
　 In 5 of the 9 categories related to knowledge of 
NIPT,  a greater proportion of pregnant women aged
ｧ35 years responded that they knewthe facts than 
women agedｦ34 years.
　 Attitude to NIPT
　 1. Indication and facilities to provide NIPT
　 When asked whether NIPT should be implemented 
in Japan,  41.8ｵ women responded that they “agreed” 
with the implementation and 50.1ｵ “agreed subject to 
conditions.” Only 4.1ｵ were “opposed” to its imple-
mentation (Table 3).
　 When asked who should be the subject of NIPT,  a 
high proportion of women (69.1ｵ) felt that “NIPT 
should be oﬀered to all pregnant women who want it.” 
Some (6.3ｵ) responded that they believed it “should 
be used as a mass screening program for all pregnant 
women.” Only 19.2ｵ of women stated that NIPT should 
be “limited to pregnant women who have a high risk of 
carrying a fetus with a chromosomal abnormality” and 
5.4ｵ believed that it should be given to “all pregnant 
women at or above a certain age”; both of those are 
currently the recommended subjects according to the 
Japanese NIPT guidelines.  A signiﬁcantly high num-
ber of women who responded that NIPT should be 
implemented “as a mass screening program for all 
pregnant women” wereｦ34 years of age (8.1ｵ).
　 When asked where they would like to undergo 
NIPT,  41.5ｵ (231/557) responded “at a University 
hospital,” 21.5ｵ (120/557) responded “at a perinatal 
maternal and child medical center,” and 67.0ｵ 
(373/557) responded “at a general obstetric hospital/
clinic.” A signiﬁcantly high proportion of women aged
ｧ35 years (28.2ｵ vs. 18.5ｵ) gave the response “at 
a perinatal maternal and child medical center.”
　 2. Support prior to NIPT
　 Most women (92.3ｵ) responded that they would 
“want a detailed explanation related to the test” when 
deciding whether or not to undergo it (Table 4).  Of 
them,  63.7ｵ would want an explanation from an 
“obstetrician specializing in genetic medicine.” In 
contrast to this,  the proportion that responded from 
an “accredited genetic counselor” and a “genetic spe-
cialist nurse” was low (17.4ｵ and 10.2ｵ,  respectively).  
Among women agedｧ35 years,  28.7ｵ responded that 
they would want an explanation from an “accredited 
genetic counselor”,  which was signiﬁcantly higher than 
those agedｦ34 years (12.3ｵ).
　 Furthermore,  when undergoing NIPT,  69.8ｵ of 
respondents would “like psychological counseling” and 
63.8ｵ would prefer receiving it from a psychological 
counselor.
　 3. Support for women with a positive NIPT 
result
　 If NIPT results are positive,  84.9ｵ women 
responded that they would “want support” (Table 5).  
Of these,  65.1ｵ responded that they would “want 
psychological support.” When asked from whom they 
would like to hear an explanation,  a high proportion 
(82.8ｵ) responded they would prefer “a pediatrician 
knowledgeable about Down syndrome and other condi-
tions.” In addition,  a relatively high proportion (41.4ｵ) 
of these women stated that they would like to “hear 
from the mothers of children with Down syndrome.” 
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Table 3　 Conditions for implementing NIPT
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Implementation of NIPT in Japan
　Agree 233 (41.8%) 162 (42.3%) 71 (40.8%) 0.676
　Agree subject to certain conditions 279 (50.1%) 190 (49.6%) 89 (51.1%)
　Oppose 23 (4.1%) 14 (3.7%) 9 (5.2%)
　No answer 22 (3.9%) 17 (4.4%) 5 (2.9%)
Conditions for implementing NIPT in Japan
Focus of NIPT implementation
　All pregnancies 35 (6.3%) 31 (8.1%) 4 (2.3%) ＜0.05
　All pregnant women wishing to undergo NIPT 385 (69.1%) 265 (69.2%) 120 (69.0%)
Limited to pregnant women with a high possibility of
　chromosomal abnormality
107 (19.2%) 69 (18.0%) 38 (21.8%)
　Limited only to pregnant women over a certain age 30 (5.4%) 18 (4.7%) 12 (6.9%)
Furthermore,  58.5ｵ of respondents stated that if it 
was prenatally determined that they were carrying a 
child with Down syndrome,  they would “want to meet 
and talk with a group or organization with experience 
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Table 4　 Support prior to NIPT implementation
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Would like detailed explanation when deciding whether or not to 
undergo NIPT
514 (92.3%) 350 (91.4%) 164 (94.3%) 0.240
Preferred source of explanation
　Obstetrician specializing in genetic medicine 355 (63.7%) 237 (61.9%) 118 (67.8%) 0.333
　Obstetrician currently caring for pregnancy 343 (61.6%) 235 (61.4%) 108 (62.1%) 0.772
　Pediatric genetic specialist 121 (21.7%) 84 (21.9%) 37 (21.3%) 0.720
　Accredited genetic counselor 97 (17.4%) 47 (12.3%) 50 (28.7%) ＜0.001
　Genetics specialist nurse 57 (10.2%) 38 (9.9%) 19 (10.9%) 0.806
　Obstetric nurse 38 (6.8%) 26 (6.8%) 12 (6.9%) 0.964
　Nurse 16 (2.9%) 12 (3.1%) 4 (2.3%) 0.547
　Clinical psychologist 14 (2.5%) 8 (2.1%) 6 (3.4%) 0.268
Would like psychological counseling when undergoing NIPT 389 (69.8%) 263 (68.7%) 126 (72.4%) 0.372
Preferred source of psychological counseling
　Psychological counselor 248 (63.8%) 167 (63.5%) 81 (64.3%) 0.880
　Obstetrician 167 (42.9%) 109 (41.4%) 58 (46.0%) 0.051
　Clinical psychologist 146 (37.5%) 90 (34.2%) 56 (44.4%) 0.392
　Obstetric nurse 98 (25.2%) 70 (26.6%) 28 (22.2%) 0.882
　Nurse 48 (12.3%) 32 (12.2%) 16 (12.7%) 0.356
　Other 8 (2.1%) 6 (2.3%) 2 (1.6%)
Table 5　 Support during fetal chromosome diagnosis using amniocentesis subsequent to undergoing NIPT
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Would want support if NIPT test result is positive 473 (84.9%) 322 (84.1%) 151 (86.8%) 0.408
Preferred means of support
　Psychological support 308 (65.1%) 202 (62.7%) 106 (70.2%) 0.112
　Information provision
Explanation from pediatrician knowledgeable about Down 
syndrome and other conditions
392 (82.8%) 270 (83.9%) 122 (80.8%) 0.411
Want to meet and talk with mothers of children with Down 
syndrome
196 (41.4%) 149 (43.5%) 56 (37.1%) 0.188
　　Meet children with Down syndrome 78 (16.5%) 52 (16.1%) 26 (17.2%) 0.770
Interview with a group or organization of people
　with experience regarding Down syndrome
46 (9.7%) 26 (8.1%) 20 (13.2%) 0.077
Interview with a group or organization of people with experience 
on such matters, in cases where prenatal testing establishes that 
the fetus has Down syndrome
　Strongly want 25 (4.5%) 19 (5.0%) 6 (3.4%) 0.848
　Want 326 (58.5%) 222 (58.0%) 104 (59.8%)
　Do not want 177 (31.8%) 121 (31.6%) 56 (32.2%)
　Absolutely do not want 21 (3.8%) 16 (4.2%) 5 (2.9%)
　No response 8 (1.4%) 5 (1.3%) 3 (1.4%)
dealing with such matters.”
　 4. Attitude to fetal chromosome diagnosis using 
amniocentesis in the case of a positive NIPT result
　 If a positive NIPT result was returned,  74.0ｵ of 
women responded that they would “undergo fetal 
chromosome diagnosis using amniocentesis” (Table 6).  
A further 20.3ｵ responded that they would “continue 
the pregnancy without undergoing fetal chromosome 
diagnosis using amniocentesis,” while 5.7ｵ responded 
that they would “terminate the pregnancy without 
undergoing fetal chromosome diagnosis using amnio-
centesis.”
　 When asked for the reasons why they would con-
tinue the pregnancy without undergoing fetal chromo-
some diagnosis using amniocentesis,  66.4ｵ (75/113) 
responded that they would “want to raise the child 
even if it had an abnormality,” while 49.6ｵ (56/113) 
responded that “fetal chromosome diagnosis using 
amniocentesis carries a risk of miscarriage.”
　 When the subset who would terminate the preg-
nancy without undergoing fetal chromosome diagnosis 
using amniocentesis were asked the reasons for this 
choice 59.4ｵ (19/32) responded that they would 
“terminate the pregnancy if there was even a small 
chance of abnormality,” while 40.6ｵ (13/32) felt that 
it would be a “pity for the fetus to have to terminate it 
at a later date” when further tests conclusively show 
abnormality.  And 25.0ｵ of women (8/32) responded 
that “the anxiety is too great to wait several more 
weeks” for further testing to be completed.
　 Looking at the background of the 5.7ｵ of pregnant 
women who would “terminate the pregnancy without 
undergoing fetal chromosome diagnosis using amnio-
centesis,” 62.5ｵ (20/32) “agree” that NIPT should be 
performed in Japan,  while 56.3ｵ (18/32) responded 
that they would “not want any support” prior to NIPT 
implementation if they received a positive result from 
NIPT,  and 53.1ｵ (17/32) responded that they would 
“not want psychological counseling” when undergoing 
NIPT.
　 If the results of NIPT were positive,  a lower 
proportion of women agedｧ35 years responded that 
they would “undergo fetal chromosome diagnosis using 
amniocentesis” (65.5ｵ) (Table 6).  In addition,  a high 
proportion of women agedｧ35 years responded that 
they would “terminate the pregnancy without undergo-
ing fetal chromosome diagnosis using amniocentesis” 
(8.6ｵ,  15/174).
　 Parity and attitude to NIPT among women 
agedｧ35 years
　 Among women agedｧ35 years,  there were no 
signiﬁcant diﬀerences between primiparous and mul-
tiparous women in the results for “Knowledge of 
NIPT”,  “Conditions for implementing NIPT”,  “Support 
prior to NIPT implementation”,  “Support during fetal 
chromosome diagnosis using amniocentesis subsequent 
to undergoing NIPT”,  and “Attitude to fetal chromo-
some diagnosis using amniocentesis subsequent to a 
positive NIPT result.”
Discussion
　 Knowledge of NIPT. Japanese newspapers 
reported extensively on NIPT in 2012.  It was reported 
that NIPT can be implemented simply by collecting a 
maternal blood sample,  and that at least 99ｵ of all 
pregnancies with Down syndrome can be detected.  
When NIPT was implemented in Japan in 2013,  
aspects that were relatively well known by pregnant 
Japanese women were the facts that “blood is col-
lected from the pregnant woman and tested” and that 
“the test can screen whether or not the fetus has Down 
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Table 6　 Awareness of fetal chromosome diagnosis using amniocentesis subsequent to a positive NIPT result
Total
(n＝557)
ｦ34 years of age
(n＝383)
ｧ35 years of age
(n＝174) p value
Would you undergo fetal chromosome diagnosis
　using amniocentesis subsequent to a positive NIPT result?
Would undergo fetal chromosome diagnosis
　using amniocentesis
412 (74.0%) 298 (77.8%) 114 (65.5%) ＜0.01
Would continue pregnancy without undergoing
　fetal chromosome diagnosis using amniocentesis
113 (20.3%) 68 (17.8%) 45 (25.9%)
Would terminate the pregnancy without undergoing
　fetal chromosome diagnosis
32 (5.7%) 17 (4.4%) 15 (8.6%)
syndrome.” Only a few pregnant women were aware 
that “NIPT positive predictive value can vary depend-
ing on the subject tested,” and that “if a positive test 
result is returned in NIPT,  it is necessary to undergo 
fetal chromosome diagnosis using amniocentesis to 
establish a deﬁnitive diagnosis.” For these reasons,  
some women may have opted for medical termination 
of a pregnancy merely because they have received a 
positive NIPT result.  Thus,  this information must be 
provided to a pregnant woman before she undergoes 
NIPT or even before she becomes pregnant.
　 Attitude of the implementation of NIPT.
Our study results demonstrate that many pregnant 
women approve of NIPT implementation in Japan,  and 
that they would like to see a relaxation in the current 
restrictions [18].  However,  a previous study revealed 
that people were more positive about NIPTʼs clinical 
applications the less they knew about it [19].  In our 
study,  ＜10ｵ of pregnant women responded that they 
“knew a lot” about NIPT,  and ＜30ｵ knew anything 
about its predictive values.  This disparity in knowl-
edge and the fact that 90ｵ of women approved of 
NIPT implementation indicate that women are giving 
their approval without having suﬃcient knowledge 
about it.  Although only a few facilities oﬀer the test 
in Japan,  our study results reveal that women prefer 
the general obstetric hospital or clinic where they are 
receiving pregnancy health care rather than a doctor 
they meet for the ﬁrst time at a more distant hospital.  
When the facilities providing NIPT in Japan increase 
in number,  a thoughtful discussion on the institutional 
conditions for implementing NIPT will be necessary.
　 Support when implementing NIPT. In this 
study,  90ｵ of respondents hoped for a detailed 
explanation when deciding whether to undergo NIPT.  
At present,  the Japanese guidelines recommend 
undergoing NIPT only after receiving genetic counsel-
ing from an obstetrician and pediatric genetic special-
ist or an approved genetic counselor.  Consistent with 
this,  we found that a high proportion of women 
(around 60ｵ) hoped for an explanation from an obste-
trician,  particularly at the hospital they were attend-
ing regularly.  This may be because women feel more 
comfortable taking advice from familiar medical staﬀ.  
When implementing prenatal diagnoses in order to 
provide a pregnant woman with suﬃcient information 
and reduce anxiety,  doctors and midwives who have 
been trained in the area must counsel the women [13,  
20-23].  However,  the numbers of obstetric genetic 
specialists,  pediatric genetic specialists,  and approved 
genetic counselors in Japan is insuﬃcient [24].  
Training of not only obstetricians but also midwives 
and nurses should be required to give informed advice 
in order to implement NIPT testing at local obstetric 
clinics.
　 Support for positive results in NIPT. The 
results of our study indicate that many women will 
require support (e.g.,  medical and psychological) if 
they receive a positive test result from the NIPT.  
Approximately 70ｵ women in our survey wanted to 
receive a “detailed explanation from a pediatrician 
knowledgeable about Down syndrome and other associ-
ated complications.” Pediatricians not only provide 
medical support but also oﬀer the necessary psycho-
logical and social support for both the aﬀected infant 
and his/her family and implement long-term follow-up 
for children with congenital abnormalities [25].  Thus 
the access of women receiving a positive NIPT result 
to a pediatrician,  who can take a neutral position and 
provide medical advice and psychological support,  may 
assist them in reaching an appropriate decision.  This,  
in turn,  will signiﬁcantly impact the subsequent deci-
sions.  Furthermore,  around 30ｵ of pregnant women 
also indicated a desire to hear from other mothers of 
children with Down syndrome.  At present in Japan,  
few medical staﬀ are proactive in this area and there 
is no system in place to promote this kind of informa-
tional exchange.  Prior to undergoing NIPT,  it would 
be preferable for pregnant women or for people who 
may have children in the future to be given an oppor-
tunity to learn speciﬁcally about the lifestyles of 
children and adults with chromosomal abnormalities 
such as Down syndrome.
　 Deﬁnitive diagnosis if the NIPT result is 
positive. Undergoing prenatal diagnosis can cause 
a lot of conﬂict and anxiety in women [26,  27].  
Mental preparation is thus necessary before undergo-
ing NIPT.  NIPT can be implemented simply by draw-
ing blood from the mother,  and in certain subjects 
provides a high degree of accuracy [4-8].  The 
results of NIPT indicate the probability that varies 
depending on the age of the mother and individual risk 
of chromosomal abnormality [4,  6].  In other words,  
NIPT is a screening test,  and when the results are 
positive,  amniocentesis must be undertaken to estab-
lish a deﬁnitive diagnosis.  However,  only 70ｵ of 
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women in our study responded that they would undergo 
amniocentesis if their NIPT result was positive,  and 
5.7ｵ responded that they would opt for medical ter-
mination of pregnancy without undergoing amniocente-
sis.  In previous research into the respondents who 
would have NIPT,  30.7ｵ said that they were ʻlikelyʼ 
to terminate an aﬀected pregnancy [28].  In the pres-
ent study,  more than half of these 5.7ｵ women 
responded that if they received a positive NIPT 
result,  they would “not want any support,” and that 
when undergoing NIPT they would “not want psycho-
logical counseling”; this further indicates the high 
possibility that these women would opt for medical 
termination of the pregnancy based solely on their own 
interpretation of the NIPT result.
　 Some women may decide not to undergo NIPT or 
to continue the pregnancy even if they receive a posi-
tive NIPT result without undergoing amniocentesis.  
In such women,  NIPT may be suggested for deciding 
the delivery method or preparing for the requisite 
post-natal care; alternatively,  it may be appropriate 
to select fetal chromosome diagnosis using amniocen-
tesis right from the start.  It is necessary that people 
have knowledge regarding fetal chromosomal abnor-
malities prior to pregnancy,  for example,  during 
school education,  and that opportunities be created 
for them to think about these medical,  social and 
ethical issues.  A system is required whereby pregnant 
women should not be allowed to undergo the test 
without suﬃcient knowledge of the birth implications 
of NIPT test results,  or of the conﬂicts and anxieties 
that can occur when undergoing NIPT.
　 Comparison by age. Compared with women 
agedｦ34 years,  a greater proportion of pregnant 
women agedｧ35 years were knowledgeable about 
NIPT.  This is probably because women on reaching 
the age ofｧ35 years themselves become aware of the 
fact that they are more prone to giving birth to chil-
dren with chromosomal abnormalities and therefore 
look for information on the subject.  There was no 
signiﬁcant diﬀerence by age group in attitude to NIPT 
implementation,  support prior to or subsequent to 
undergoing the test,  or the implementation of fetal 
chromosome diagnosis using amniocentesis.  Thus,  it 
will be necessary to ensure that suﬃcient explanation 
and support prior to or subsequent to the test is given 
to all women seeking NIPT regardless of their age.
　 In conclusion,  the present study results revealed 
that pregnant Japanese women have a low level of 
knowledge regarding NIPT,  and that in some cases,  
their response to the test results may contradict their 
real intentions.  Approximately 90ｵ of the pregnant 
women surveyed agreed with its implementation in 
Japan and wished that the test was more easily avail-
able than under the current system.  This may,  how-
ever,  result from their lack of knowledge and inap-
propriate information.  Furthermore,  some women may 
undergo NIPT without adequate support or informa-
tion and then be subjected to distress and conﬂict by 
the results,  and may opt for medical termination of 
pregnancy without deﬁnitive diagnosis testing.  A 
system is required that encompasses the need for 
psychological support for pregnant women both when 
deciding on whether to undergo NIPT and when the 
NIPT result is positive; such a program would allow 
women to consider what the life of a child with Down 
syndrome or other chromosomal abnormality may be 
like.  Public awareness of people with Down syndrome 
or other chromosomal abnormalities could also lead to 
their improved welfare in society.
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